Gsk-3 β inhibitors mimic the cardioprotection mediated by ischemic pre- and postconditioning in hypertensive rats

BioMed Research International

Volumn 2013, Issue , 2013, Pages

  González Arbeláez, Luisa F ^a   Pérez Núñez, Ignacio A ^a   Mosca, Susana M ^a  

^a UNIVERSIDAD NACIONAL DE LA PLATA   (Argentina)

Author keywords

[No Author keywords available]

Indexed keywords

COPPER ZINC SUPEROXIDE DISMUTASE; GLUTATHIONE; GLYCOGEN SYNTHASE KINASE 3 INHIBITOR; GLYCOGEN SYNTHASE KINASE 3BETA; LITHIUM CHLORIDE; PROTEIN KINASE B; THIOBARBITURIC ACID REACTIVE SUBSTANCE; GLYCOGEN SYNTHASE KINASE 3; GLYCOGEN SYNTHASE KINASE 3 BETA; INDIRUBIN 3' MONOXIME; INDIRUBIN-3'-MONOXIME; INDOLE DERIVATIVE; OXIME;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; HEART INFARCTION SIZE; HEART LEFT VENTRICLE ENDDIASTOLIC PRESSURE; HEART MUSCLE CONTRACTILITY; HEART PROTECTION; HEART WEIGHT; ISCHEMIC PRECONDITIONING; ISOLATED HEART; LIPID PEROXIDATION; MITOCHONDRIAL PERMEABILITY; MITOCHONDRION SWELLING; NONHUMAN; OXIDATIVE STRESS; PROTEIN EXPRESSION; RAT; REPERFUSION INJURY; SIGNAL TRANSDUCTION; SPONTANEOUSLY HYPERTENSIVE RAT; ANIMAL; DRUG ANTAGONISM; DRUG EFFECT; GENETICS; HEART; HUMAN; HYPERTENSION; ISCHEMIC POSTCONDITIONING; METABOLISM; METHODOLOGY; ORGAN CULTURE TECHNIQUE; PATHOLOGY; PHOSPHORYLATION;

ANIMALS; GLYCOGEN SYNTHASE KINASE 3; HEART; HUMANS; HYPERTENSION; INDOLES; ISCHEMIC POSTCONDITIONING; ISCHEMIC PRECONDITIONING; LIPID PEROXIDATION; LITHIUM CHLORIDE; ORGAN CULTURE TECHNIQUES; OXIMES; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS C-AKT; RATS; REPERFUSION INJURY;

EID: 84888632480     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2013/317456     Document Type: Article

References (47)

1. Friehs I., Del Nido P. J., Increased susceptibility of hypertrophied hearts to ischemic injury. Annals of Thoracic Surgery 2003 75 2 S678 S684 2-s2.0-0037312402 10.1016/S0003-4975(02)04692-1 (Pubitemid 36184548)
2. Chen H., Azuma M., Maeda K., Kajimoto N., Higashino H., Impaired heart function and noradrenaline release after ischaemia in stroke-prone spontaneously hypertensive rats. Clinical and Experimental Pharmacology and Physiology 2000 27 9 664 670 2-s2.0-0033839983 10.1046/j.1440-1681.2000.03325.x (Pubitemid 30666184)
3. Yano T., Miki T., Tanno M., Kuno A., Itoh T., Takada A., Sato T., Kouzu H., Shimamoto K., Miura T., Hypertensive hypertrophied myocardium is vulnerable to infarction and refractory to erythropoietin-induced protection. Hypertension 2011 57 1 110 115 2-s2.0-78650839489 10.1161/HYPERTENSIONAHA.110.158469
4. Fantinelli J. C., Pérez Núñez I. A., González Arbeláez L. F., Schinella G. R., Mosca S. M., Participation of mitochondrial permeability transition pore in the effects of ischemic preconditioning in hypertrophied hearts: role of NO and mitoK(ATP). International Journal of Cardiology 2013 166 1 173 180 10.1016/j.ijcard.2011.10. 103
5. Fantinelli J. C., Mosca S. M., Comparative effects of ischemic pre and postconditioning on ischemia-reperfusion injury in spontaneously hypertensive rats (SHR). Molecular and Cellular Biochemistry 2007 296 1-2 45 51 2-s2.0-34447526639 10.1007/s11010-006-9296-2
6. Ferdinandy P., Schulz R., Baxter G. F., Interaction of cardiovascular risk factors with myocardial ischemia/reperfusion injury, preconditioning, and postconditioning. Pharmacological Reviews 2007 59 4 418 458 2-s2.0-37549038706 10.1124/pr.107.06002
7. Speechly-Dick M. E., Baxter G. F., Yellon D. M., Ischemic preconditioning protects hypertrophied myocardium. Cardiovascular Research 1994 28 7 1025 1029 2-s2.0-0028168212
8. Ebrahim Z., Yellon D. M., Baxter G. F., Ischemic preconditioning is lost in aging hypertensive rat heart: independent effects of aging and longstanding hypertension. Experimental Gerontology 2007 42 8 807 814 2-s2.0-34447299116 10.1016/j.exger.2007.04.005 (Pubitemid 47058862)
9. Dai W., Simkhovich B. Z., Kloner R. A., Ischemic preconditioning maintains cardioprotection in aging normotensive and spontaneously hypertensive rats. Experimental Gerontology 2009 44 5 344 349 2-s2.0-64449084479 10.1016/j.exger.2009.02.005
10. Penna C., Tullio F., Moro F., Folino A., Merlino A., Pagliaro P., Effects of a protocol of ischemic postconditioning and/or Captopril in hearts of normotensive and hypertensive rats. Basic Research in Cardiology 2010 105 2 181 192 2-s2.0-77950350159 10.1007/s00395-009-0075-6
11. Penna C., Tullio F., Perrelli M.-G., Moro F., Abbadessa G., Piccione F., Carriero V., Racca S., Pagliaro P., Ischemia/reperfusion injury is increased and cardioprotection by a postconditioning protocol is lost as cardiac hypertrophy develops in nandrolone treated rats. Basic Research in Cardiology 2011 106 3 409 420 2-s2.0-79955536647 10.1007/s00395-010-0143-y
12. Tsujimoto Y., Shimizu S., Role of the mitochondrial membrane permeability transition in cell death. Apoptosis 2007 12 5 835 840 2-s2.0-34247485841 10.1007/s10495-006-0525-7 (Pubitemid 46653286)
13. Di Lisa F., Canton M., Carpi A., Kaludercic N., Menabò R., Menazza S., Semenzato M., Mitochondrial injury and protection in ischemic pre-and postconditioning. Antioxidants and Redox Signaling 2011 14 5 881 891 2-s2.0-79551675865 10.1089/ars.2010.3375
14. Nishino Y., Webb I. G., Davidson S. M., Ahmed A. I., Clark J. E., Jacquet S., Shah A. M., Miura T., Yellon D. M., Avkiran M., Marber M. S., Glycogen synthase kinase-3 inactivation is not required for ischemic preconditioning or postconditioning in the mouse. Circulation Research 2008 103 3 307 314 2-s2.0-51749092348 10.1161/CIRCRESAHA.107.169953
15. Skyschally A., van Caster P., Boengler K., Gres P., Musiolik J., Schilawa D., Schulz R., Heusch G., Ischemic postconditioning in pigs: no causal role for risk activation. Circulation Research 2009 104 1 15 18 2-s2.0-59649114814 10.1161/CIRCRESAHA.108.186429
16. Gomez L., Paillard M., Thibault H., Derumeaux G., Ovize M., Inhibition of GSK3 β by postconditioning is required to prevent opening of the mitochondrial permeability transition pore during reperfusion. Circulation 2008 117 21 2761 2768 2-s2.0-44449133771 10.1161/CIRCULATIONAHA.107.755066 (Pubitemid 351770456)
17. Gross E. R., Hsu A. K., Gross G. J., Delayed cardioprotection afforded by the glycogen synthase kinase 3 inhibitor SB-216763 occurs via a KATP- and MPTP-dependent mechanism at reperfusion. The American Journal of Physiology 2008 294 3 H1497 H1500 2-s2.0-41549166524 10.1152/ajpheart.01381.2007 (Pubitemid 351468753)
18. Jope R. S., Johnson G. V. W., The glamour and gloom of glycogen synthase kinase-3. Trends in Biochemical Sciences 2004 29 2 95 102 2-s2.0-0442276554 10.1016/j.tibs.2003.12.004 (Pubitemid 38186580)
19. Juhaszova M., Zorov D. B., Yaniv Y., Nuss H. B., Wang S., Sollott S. J., Role of glycogen synthase kinase-3 β in cardioprotection. Circulation Research 2009 104 11 1240 1252 2-s2.0-67649882599 10.1161/CIRCRESAHA.109.197996
20. Nishihara M., Miura T., Miki T., Tanno M., Yano T., Naitoh K., Ohori K., Hotta H., Terashima Y., Shimamoto K., Modulation of the mitochondrial permeability transition pore complex in GSK-3 β -mediated myocardial protection. Journal of Molecular and Cellular Cardiology 2007 43 5 564 570 2-s2.0-35348988663 10.1016/j.yjmcc.2007.08.010 (Pubitemid 47615050)
21. Pastorino J. G., Hoek J. B., Shulga N., Activation of glycogen synthase kinase 3 β disrupts the binding of hexokinase II to mitochondria by phosphorylating voltage-dependent anion channel and potentiates chemotherapy-induced cytotoxicity. Cancer Research 2005 65 22 10545 10554 2-s2.0-28544436922 10.1158/0008-5472.CAN-05-1925 (Pubitemid 41743749)
22. Barillas R., Friehs I., Cao-Danh H., Martinez J. F., del Nido P. J., Inhibition of glycogen synthase kinase-3 β improves tolerance to ischemia in hypertrophied hearts. Annals of Thoracic Surgery 2007 84 1 126 133 2-s2.0-34250347187 10.1016/j.athoracsur.2007.02.015 (Pubitemid 46921104)
23. Lassègue B., Griendling K. K., Reactive oxygen species in hypertension. The American Journal of Hypertension 2004 17 852 860
24. Downey J. M., Free radicals and their involvement during long-term myocardial ischemia and reperfusion. Annual Review of Physiology 1990 52 487 504 2-s2.0-0025309602 (Pubitemid 20103551)
25. Quarrie R., Lee D. S., Steinbaugh G., Cramer B., Erdahl W., Pfeiffer D. R., Zweier J. L., Crestanello J. A., Ischemic preconditioning preserves mitochondrial membrane potential and limits reactive oxygen species production. Journal of Surgical Research 2012 178 8 17
26. Kin H., Wang N.-P., Mykytenko J., Reeves J., Deneve J., Jiang R., Zatta A. J., Guyton R. A., Vinten-Johansen J., Zhao Z.-Q., Inhibition of myocardial apoptosis by postconditioning is associated with attenuation of oxidative stress-mediated nuclear factor- B translocation and TNF release. Shock 2008 29 6 761 768 2-s2.0-44449090898 10.1097/SHK.0b013e31815cfd5a (Pubitemid 351769941)
27. Guide for the Care and Use of Laboratory Animals. NIH Publication no. 85-23, 1985
28. Buege J. A., Aust S. D., Microsomal lipid peroxidation. Methods in Enzymology 1978 52 302 310 2-s2.0-0017872475 10.1016/S0076-6879(78)52032-6
29. Baines C. P., Zhang J., Wang G.-W., Zheng Y.-T., Xiu J. X., Cardwell E. M., Bolli R., Ping P., Mitochondrial PKC ε and MAPK form signaling modules in the murine heart: enhanced mitochondrial PKC ε -MAPK interactions and differential MAPK activation in PKC ε -induced cardioprotection. Circulation Research 2002 90 4 390 397 2-s2.0-0037040343 10.1161/01.RES. 0000012702.90501.8D (Pubitemid 34633907)
30. Beavis A. D., Brannan R. D., Garlid K. D., Swelling and contraction of the mitochondrial matrix. I: a structural interpretation of the relationship between light scattering and matrix volume. Journal of Biological Chemistry 1985 260 25 13424 13433 2-s2.0-0022402287 (Pubitemid 16192286)
31. Miura T., Miki T., GSK-3 β a therapeutic target for cardiomyocyte protection. Circulation Journal 2009 73 7 1184 1192 2-s2.0-68149166465 10.1253/circj.CJ-09-0284
32. Gross E. R., Hsu A. K., Gross G. J., Opioid-induced cardioprotection occurs via glycogen synthase kinase β inhibition during reperfusion in intact rat hearts. Circulation Research 2004 94 7 960 966 2-s2.0-1842841258 10.1161/01.RES.0000122392.33172.09 (Pubitemid 38490074)
33. Obame F. N., Plin-Mercier C., Assaly R., Zini R., Dubois-Randé J. L., Berdeaux A., Morin D., Cardioprotective effect of morphine and a blocker of glycogen synthase kinase 3 β SB216763 [3-(2,4-dichlorophenyl)-4(1-methyl- 1H-indol-3-yl)-1H- pyrrole-2,5-dione], via inhibition of the mitochondrial permeability transition pore. Journal of Pharmacology and Experimental Therapeutics 2008 326 1 252 258 2-s2.0-45749086498 10.1124/jpet.108.138008 (Pubitemid 351872117)
34. Zhan F., Phiel C. J., Spece L., Gurvich N., Klein P. S., Inhibitory phosphorylation of glycogen synthase kinase-3 (GSK-3) in response to lithium: evidence for autoregulation of GSK-3. Journal of Biological Chemistry 2003 278 35 33067 33077 2-s2.0-0042357237 10.1074/jbc.M212635200 (Pubitemid 37055753)
35. Ryves W. J., Harwood A. J., Lithium inhibits glycogen synthase kinase-3 by competition for magnesium. Biochemical and Biophysical Research Communications 2001 280 3 720 725 2-s2.0-0034805180 10.1006/bbrc.2000.4169 (Pubitemid 32924489)
36. Zhai P., Sciarretta S., Galeotti J., Volpe M., Sadoshima J., Differential roles of gsk-3 β during myocardial ischemia and ischemia/reperfusion. Circulation Research 2011 109 5 502 511 2-s2.0-80052147341 10.1161/CIRCRESAHA. 111.249532
37. Pap M., Cooper G. M., Role of glycogen synthase kinase-3 in the phosphatidylinositol 3- kinase/Akt cell survival pathway. Journal of Biological Chemistry 1998 273 32 19929 19932 2-s2.0-0032493729 10.1074/jbc.273.32.19929 (Pubitemid 28377539)
38. Zhu M., Feng J., Lucchinetti E., Fischer G., Xu L., Pedrazzini T., Schaub M. C., Zaugg M., Ischemic postconditioning protects remodeled myocardium via the PI3K-PKB/Akt reperfusion injury salvage kinase pathway. Cardiovascular Research 2006 72 1 152 162 2-s2.0-33748177384 10.1016/j.cardiores.2006.06.027 (Pubitemid 44310638)
39. Hausenloy D. J., Ong S.-B., Yellon D. M., The mitochondrial permeability transition pore as a target for preconditioning and postconditioning. Basic Research in Cardiology 2009 104 2 189 202 2-s2.0-62249102192 10.1007/s00395-009-0010-x
40. Jin Z.-Q., Zhou H.-Z., Cecchini G., Gray M. O., Karliner J. S., MnSOD in mouse heart: acute responses to ischemic preconditioning and ischemia-reperfusion injury. The American Journal of Physiology 2005 288 6 H2986 H2994 2-s2.0-19344364055 10.1152/ajpheart.01144.2004 (Pubitemid 40720684)
41. Terashima Y., Sato T., Yano T., Maas O., Itoh T., Miki T., Tanno M., Kuno A., Shimamoto K., Miura T., Roles of phospho-GSK-3 β in myocardial protection afforded by activation of the mitochondrial KATP channel. Journal of Molecular and Cellular Cardiology 2010 49 5 762 770 2-s2.0-77957220638 10.1016/j.yjmcc.2010.08.001
42. Miyamoto S., Murphy A. N., Brown J. H., Akt mediates mitochondrial protection in cardiomyocytes through phosphorylation of mitochondrial hexokinase-II. Cell Death and Differentiation 2008 15 3 521 529 2-s2.0-39449114808 10.1038/sj.cdd.4402285 (Pubitemid 351267303)
43. Das S., Wong R., Rajapakse N., Murphy E., Steenbergen C., Glycogen synthase kinase 3 inhibition slows mitochondrial adenine nucleotide transport and regulates voltage-dependent anion channel phosphorylation. Circulation Research 2008 103 9 983 991 2-s2.0-55449092939 10.1161/CIRCRESAHA.108.178970
44. Costa A. D. T., Garlid K. D., Intramitochondrial signaling: interactions among mitoKATP, PKC ε ROS, and MPT. The American Journal of Physiology 2008 295 2 H874 H882 2-s2.0-52449115978 10.1152/ajpheart.01189.2007
45. Leichtweis S., Ji L. L., Glutathione deficiency intensifies ischaemia-reperfusion induced cardiac dysfunction and oxidative stress. Acta Physiologica Scandinavica 2001 172 1 1 10 2-s2.0-0034818864 10.1046/j.1365-201X. 2001.00820.x (Pubitemid 32862755)
46. Slodzinski M. K., Aon M. A., O'Rourke B., Glutathione oxidation as a trigger of mitochondrial depolarization and oscillation in intact hearts. Journal of Molecular and Cellular Cardiology 2008 45 5 650 660 2-s2.0-55649118870 10.1016/j.yjmcc.2008.07.017
47. Halestrap A. P., Mitochondria and reperfusion injury of the heart-A holey death but not beyond salvation. Journal of Bioenergetics and Biomembranes 2009 41 2 113 121 2-s2.0-67650673384 10.1007/s10863-009-9206-x